Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • Breakthrough Discoveries
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Tze Yee Lim Image

      Tze Yee Lim, PhD

      Department of Radiation Physics, Division of Radiation Oncology

      Present Title & Affiliation

      Primary Appointment

      Full Member, Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences

      Associate Professor, Radiation Physics, The University of Texas MD Anderson Cancer Center

      Education & Training

      Degree-Granting Education

      2016University of Texas MD Anderson Cancer Center, US, Ph.D. in Medical Physics
      2011Drexel University, US, B.S. in Physics (Minor: Mathematics)

      Postgraduate Training

      2016-2018Clinical Residency, Therapeutic Medical Physics, University of California San Diego, San Diego, California

      Licenses & Certifications

      2025Essentials of Quality Improvement Certification (University of Texas MD Anderson Cancer Center)
      2025Applying Lean Concepts to Healthcare Processes - Introductory Level Certification (University of Texas MD Anderson Cancer Center)
      2025Six Sigma Yellow Belt Certification (University of Texas MD Anderson Cancer Center)
      2023Introduction to Human Factors (University of Texas MD Anderson Cancer Center)
      2019Medical Physicist License (Texas Medical Board)
      2019Therapeutic Medical Physics Certification (American Board of Radiology)
      2011Certificate in Medical Humanities (Drexel University)

      Experience & Service

      Faculty Academic Appointments

      Associate Member, Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, 2020 - 2025

      Assistant Professor, Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2018 - 2024

      Extramural Institutional Committee Activities

      HLMS Physics Representative, Quality and Safety Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Member, ROSI Boot Walk Trainee Seed Award Review Committee, The University of Texas MD Anderson Cancer Center, 2024

      Member, Medical Physics Program Steering Committee, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, 2023 - Present

      Radiation Physics Research Liaison, Radiation Oncology Clinical Research Council, The University of Texas MD Anderson Cancer Center, 2021 - 2025

      Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2020 - 2023

      Honors & Awards

      2026Commended Course Director (Supervised Clinical Experience in Radiation Therapy Physics), The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences
      2018Finalist, Young Investigators Symposium, AAPM Spring Clinical Meeting
      2017Research Presentation Award, University of California San Diego Research Symposium
      2013Graduate Scholarship, Cancer Prevention Research Institute of Texas (CPRIT)
      2011Med-Into-Grad Post-Graduate Fellowship, Howard Hughes Medical Institute (HHMI)

      Professional Memberships

      European Society for Radiotherapy and Oncology (ESTRO)

      2023 - Present

      Institut Fizik Malaysia (IFM)

      2018 - Present

      American Society for Radiation Oncology (ASTRO)

      2017 - Present

      American College of Radiology (ACR)

      2015 - Present

      American Association of Physicists in Medicine (AAPM)

      2013 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2022. Total Body/Marrow Irradiation at MD Anderson Cancer Center. Invited. Medical Physics Seminar, US.
      2. 2021. Total Body Irradiation. Invited. Court Research Group, US.
      3. 2020. Radiation Therapy in Malaysia and Singapore. Invited. Court Research Group, US.
      4. 2020. Head and Neck, Lymphoma, Melanoma, Sarcoma (HLMS) Physics. Invited. Faculty and Professional Staff Meeting, US.
      5. 2019. Varian RapidPlan Knowledge-Based Planning in the Clinic. Invited. Court Research Group, US.

      Regional Presentations

      1. 2022. Total Body Irradiation and Total Marrow Irradiation. Invited, US.
      2. 2021. Total Body Irradiation. Invited, US.

      National Presentations

      1. 2023. Intensity-Modulated Total Body/Marrow Irradiation. Invited, US.
      2. 2023. Clinical Implementation of VMAT-TMI (Total Marrow Irradiation). Invited, US.
      3. 2018. Characterization of the Halcyon SX1 Multi-Leaf Collimator System. Conference, US.
      4. 2017. Beyond Mere Geometry: Clinically-oriented Contour Evaluation using Knowledge-based Planning. Conference, US.
      5. 2016. MR Sequences for Post-implant Dosimetry: The MD Anderson Experience. Invited, US.
      6. 2015. Initial Patient Experience With Positive-Contrast MRI Markers for Low-Dose-Rate Prostate Brachytherapy. Conference, US.
      7. 2015. Sirius Markers for MRI-based Post-Implant Dosimetry: Initial Patient Experience. Conference, US.
      8. 2015. MR Protocol Development to Visualize Sirius MRI Markers in Prostate Brachytherapy Patients for MR Based Post-Implant Dosimetry. Conference, US.
      9. 2014. Sirius MRI Markers for Prostate Post-Implant Assessment: MR Protocol Development. Conference, US.
      10. 2013. MRI Characteristics of Cobalt Dichloride N-Acetyl Cysteine (C4) as a Contrast Agent Marker for Prostate Brachytherapy. Conference, US.
      11. 2013. Relaxivity Measurements of Cobalt Dichloride N-Acetyl Cysteine for MRI-based Prostate Brachytherapy. Conference, US.

      International Presentations

      1. 2023. Clinical Implementation of VMAT for Total Marrow Irradiation using Raystation. Conference. Vienna, AT.
      2. 2018. Clinical Advances in Medical Physics. Invited. Kuala Lumpur, MY.
      3. 2018. Medical Physics Residency in the United States. Invited. Penang, MY.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Salzillo, TC, Prajapati, S, Yu, ZH, Zhao, Y, Lim, TY, Wang, H, Wang, XA, Chen, X, Kudchadker, RJ, Lee, B, Sobremonte, A, Farooqi, AS, Mitra, D, Bishop, AJ, Tang, C, Yang, J. Quantifying setup uncertainty between computed tomography guidance and magnetic resonance guidance in intramuscular metastases radiotherapy. Journal of applied clinical medical physics 27(4), 2026. e-Pub 2026. PMID: 42003063.
      2. Yoder, A, Netherton, T, Wang, X, Lim, TY, Wang, C, Luo, D, Wang, C, Thrower, SL, Nguyen, C, Lyu, H, Scally, CP, Roland, CL, Mitra, D, Bishop, AJ, Farooqi, AS, Guadagnolo, BA. The Impact of Radiation Dose to Bowel on the Risk of Developing Gastrointestinal Toxicities When Treating Abdominopelvic Soft-Tissue Sarcomas With Preoperative Radiation Therapy. Advances in Radiation Oncology 11(2), 2026. e-Pub 2026. PMID: 41492444.
      3. Gay, SS, Gronberg, M, Mumme, R, Beadle, BM, Jhingran, A, Lim, TY, Yu, ZH, Chung, CV, Khan, M, Pinnix, CC, Shete, S, Parker, B, Netherton, T, Cardenas, CE, Court, LE. Intentional creation of suboptimal, realistic dose distributions. Journal of applied clinical medical physics 26(11), 2025. e-Pub 2025. PMID: 41144809.
      4. Lim TY, Luo D, Moradi-Kurdestany J, Wang X, Tailor R. Film measurements of kilovoltage x-ray percentage depth doses for different energies and field sizes. Br J Radiol 98(1172):1298-1304, 2025. e-Pub 2025. PMID: 40424360.
      5. Wang H, Yang J, Lee A, Phan J, Lim TY, Fuller CD, Han EY, Rhee DJ, Salzillo T, Zhao Y, Chopra N, Pham M, Castillo P, Sobremonte A, Moreno AC, Reddy JP, Rosenthal D, Garden AS, Wang X. MR-guided stereotactic radiation therapy for head and neck cancers. Clin Transl Radiat Oncol 46, 2024. e-Pub 2024. PMID: 38510980.
      6. Leone AO, Gronberg MP, Gay S, Govyadinov PA, Beadle BM, Lim TY, Whitaker TJ, Hoffman KE, Court LE, Cao W. A comparison of knowledge-based dose prediction approaches to assessing head and neck radiotherapy plan quality. medRxiv. e-Pub 2024.
      7. Hughes N, Salzillo TC, Vedam S, Lim TY, Wang X, Wang H, Mohammedsaid M, Fuller CD, Wang J, Yang J. A look-up-table development to facilitate CT simulation of MR-Linac treatment. Phys Imaging Radiat Oncol 29:100524, 2024. e-Pub 2024. PMID: 38192414.
      8. Parsons D, Lim TY, Teruel JR, Agostinelli S, Liang J, Mancosu P, Cherpak A, Stanley D, Ahn K, Guo B, Gonzalez Y, Gu X, Kim G. Considerations for intensity modulated total body or total marrow and lymphoid irradiation. Clinical and Translational Radiation Oncology 13, 2023. e-Pub 2023. PMID: 37753462.
      9. Contrera KJ, Phan J, Waguespack SG, Aldehaim M, Wang X, Lim TY, Roberts DB, Fuller C, Spiotto MT, Raza SM, DeMonte F, Hanna EY, Su SY. Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies. Head and Neck 45(10):2525-2532, 2023. e-Pub 2023. PMID: 37534890.
      10. Gronberg M, Jhingran A, Netherton T, Gay SS, Cardenas CE, Chung CV, Fuentes DA, Fuller CD, Howell RM, Khan M, Lim TY, Marquez B, Olanrewaju A, Peterson CB, Vazquez I, Whitaker TJ, Wooten ZT, Yang M, Court LE. Deep learning–based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers. Medical physics 50(11):6639-6648, 2023. e-Pub 2023. PMID: 37706560.
      11. El-Habashy, D, Wahid, K, He, R, McDonald, B, Rigert, J, Mulder, S, Lim, TY, Wang, X, Yang, J, Ding, Y, Naser, M, Ng, SP, Bahig, H, Salzillo, TC, Preston, KE, Abobakr, M, Shehata, MA, Elkhouly, EA, Alagizy, HA, Hegazy, AH, Mohammadseid, M, Terhaard, CH, Philippens, ME, Rosenthal, DI, Wang, J, Lai, SY, Dresner, A, Christodouleas, JP, Mohamed, AS, Fuller, C. Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system. Clinical and Translational Radiation Oncology 42, 2023. e-Pub 2023. PMID: 37583808.
      12. El-Habashy DM, Wahid KA, He R, McDonald B, Rigert J, Mulder SJ, Lim TY, Wang X, Yang J, Ding Y, Naser MA, Ng SP, Bahig H, Salzillo TC, Preston KE, Abobakr M, Shehata MA, Elkhouly EA, Alagizy HA, Hegazy AH, Mohammadseid M, Terhaard C, Philippens M, Rosenthal DI, Wang J, Lai SY, Dresner A, Christodouleas JC, Mohamed A, Fuller CD. Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system. Clinical and Translational Radiation Oncology 42, 2023. e-Pub 2023. PMID: 37205359.
      13. Gronberg M, Beadle BM, Garden AS, Skinner H, Gay SS, Netherton T, Cao W, Cardenas CE, Chung CV, Fuentes DA, Fuller C, Howell RM, Jhingran A, Lim TY, Marquez B, Mumme R, Olanrewaju A, Peterson CB, Vazquez I, Whitaker TJ, Wooten ZT, Yang M, Court LE. Deep Learning–Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiation Therapy Plans. Practical radiation oncology 13(3):e282-e291, 2023. e-Pub 2023. PMID: 36697347.
      14. Lim TY, Mirkovic D, Wang X, Tailor R. Devices for dosimetric measurements and quality assurance of the Xstrahl 300 orthovoltage unit. J Appl Clin Med Phys 22(4):151-157, 2021. e-Pub 2021. PMID: 33733608.
      15. Christopherson KM, Gunther JR, Fang P, Peterson SL, Roach KE, Wong PF, Mirkovic D, Lim TY, Wang H, Wang XA, Wang C, Garcia J, Dabaja BS, Pinnix CC. Decreased heart dose with deep inspiration breath hold for the treatment of gastric lymphoma with IMRT. Clin Transl Radiat Oncol 24:79-82, 2020. e-Pub 2020. PMID: 32642563.
      16. Lim TY, Dragojevic I, Hoffman D, Flores-Martinez E, Kim GY. Characterization of the HalcyonTM multileaf collimator system. J Appl Clin Med Phys 20(4):106-114, 2019. e-Pub 2019. PMID: 30889312.
      17. Lim TY, Gillespie E, Murphy J, Moore KL. Clinically Oriented Contour Evaluation Using Dosimetric Indices Generated From Automated Knowledge-Based Planning. Int J Radiat Oncol Biol Phys 103(5):1251-1260, 2019. e-Pub 2019. PMID: 30508619.
      18. Lloyd SAM, Lim TY, Fave X, Flores-Martinez E, Atwood TF, Moiseenko V. TG-51 reference dosimetry for the Halcyon™: A clinical experience. J Appl Clin Med Phys 19(4):98-102, 2018. e-Pub 2018. PMID: 29785729.
      19. Lim TY, Kudchadker RJ, Wang J, Stafford RJ, MacLellan C, Rao A, Ibbott GS, Frank SJ. Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment. Med Phys 43(7):4312, 2016. e-Pub 2016. PMID: 27370146.
      20. Lim TY, Kudchadker RJ, Wang J, Bathala T, Szklaruk J, Pugh TJ, Mahmood U, Ibbott GS, Frank SJ. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience. J Contemp Brachytherapy 8(3):235-42, 2016. e-Pub 2016. PMID: 27504133.
      21. Dhanesar SK, Lim TY, Du W, Bruno TL, Frank SJ, Kudchadker RJ. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy. J Appl Clin Med Phys 16(5):62–75, 2015. e-Pub 2015. PMID: 26699290.
      22. Lim TY, Stafford RJ, Kudchadker RJ, Sankaranarayanapillai M, Ibbott G, Rao A, Martirosyan KS, Frank SJ. MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy. Phys Med Biol 59(10):2505-16, 2014. e-Pub 2014. PMID: 24778352.
      23. Chen X, Hu X, Lim TY, Shen X, Park EK, Rosen GL. Exploiting the functional and taxonomic structure of genomic data by probabilistic topic modeling. IEEE/ACM Trans Comput Biol Bioinform 9(4):980-91, 2012. e-Pub 2012. PMID: 21844637.
      24. Rosen GL, Lim TY. NBC update: The addition of viral and fungal databases to the Naïve Bayes classification tool. BMC Res Notes 5(81), 2012. e-Pub 2012. PMID: 22293603.

      Review Articles

      1. Wang, H, Zhao, Y, Chen, X, McDonald, B, Li, Y, Xie, J, Rhee, DJ, Lim, TY, Netherton, T, Phan, J, Spiotto, MT, Lin, MH. Artificial Intelligence in Image Assisted Radiation Oncology. Cancers 18(11), 2026. e-Pub 2026. PMID: 42279299.
      2. Kovalchuk N, Simiele E, LaRiviere M, Hiniker S, Soike M, Han C, Wong J, Dandapani S, Kumar K, Parsons D, Teruel JR, Gerber NK, Guo B, Cherian S, Lim TY, Latifi K, Figura NB, Shrestha D, Grecula J, Sim AJ, Parikh R, Lo AC, Smith K, Plastaras JP, Xiao Y, Hoppe BS, Milgrom SA. Incorporating Intensity Modulated Total Body Irradiation (IMRT-TBI) into Future Cooperative Group Clinical Trials: An NRG Hematologic Malignancies Working Group-Led Report from the National Clinical Trials Network. Int J Radiat Oncol Biol Phys 125(3):714-736, 2026. e-Pub 2026. PMID: 41713515.
      3. Gronberg M, Netherton T, Beadle B, Cao W, Cardenas C, Chung C, Fuller CD, Garcia J, Hancock D, Howell RM, Jhingran A, Lee A, Lim TY, Moreno AC, Olanrewaju N, Peterson C, Whitaker TJ, Court LE. Radiotherapy Plan Quality Assessment: Current Tools and Future Directions. African Journal of Medical Physics 4(1):27-40, 2023. e-Pub 2023.

      Abstracts

      1. Netherton TJ, Celaya A, Court L, Fuentes D, Lee A, Lim TY, Luo D, Mirkovic D, Moreno A, Mumme R, Nguyen C, Parameshwaran JA, Phan J, Sjogreen C, Thrower S, Wang H, Wang C, Wang X, Beadle B. A Method to Expedite Quality Assurance for Head and Neck CTVs with Lymph Node Level Auto-contouring and Identification, 2025. e-Pub 2025.
      2. Mitrou A, Long J, Lim TY, McDonald BA, Schaefer AJ, Balter P, Svensson S, Fuller CD, Brock KK. Best- and Worst-Case Scenario: Uncertainty Bounds Informed By Daily Scanning in Weekly CBCT-Based Accumulated Dose for Head and Neck Cancer, 2025. e-Pub 2025.
      3. Wang X, Lim TY, Wang H, Dabaja B, Yang J. MR-Linac Successfully Guided the Treatment of a Free-Moving Mesenteric Mass, 2025. e-Pub 2025.
      4. Gronberg M, Beadle BM, Fuller CD, Gay S, Netherton TJ, Wood J, Cardenas CE, Peterson C, Lim TY, Howell RM, Jhingran A, Court LE. Three-dimensional dose prediction for radiotherapy plan review in a clinical trial setting, 2024. e-Pub 2024.
      5. Lim TY, Wang X. Performance of large longitudinal shifts on treatment couches with automatic couch compensation, 2024. e-Pub 2024.
      6. Yoder A, Netherton T, Wang X, Lim TY, Wang H, Luo D, Wang C, Thrower S, Farooqi A, Mitra D, Bishop A, Guadagnolo A. Evaluating the Utility of Traditional Bowel Dose Constraints when Treating Abdominal and Pelvic Sarcomas with Preoperative Radiation Therapy, 2023. e-Pub 2023.
      7. Schrank B, Manzar G, Wu S, Gunther J, Fang P, Jabbour E, Lim TY, Daver N, Cykowski M, Fuller G, Cachia D, Kamiya-Matsuoka C, Woodman K, DiNardo C, Jain N, Short N, Sasaki K, Dabaja B, Kantarjian H, Pinnix C. Dorsal Column Myelopathy Following Intrathecal Chemotherapy for Leukemia, 2023. e-Pub 2023.
      8. Wang H, Lim TY, Yang J, Fuller CD, Phan J, Wang X. Optimizing Radiation Treatment for Head and Neck Cancer with Adapt-to-Shape Planning on a 1.5T MR-Linac, 2023. e-Pub 2023.
      9. Lim TY, Wu S, Fang P, Dabaja B, Ohrt J, Gunther J, Pinnix C, Rougeau T, Sobremonte A, Wang C, Netherton T, Champlin R, Reisner Y, Shpall E, Wang X. Clinical Implementation of VMAT for Total Marrow Irradiation using Raystation, 2023. e-Pub 2023.
      10. Wang X, Tailor R, Lim TY, Dabaja B, Gunther J, Rougeau T, Pinnix C, Fang P, Wu S, Wang C. Simple AP/PA techniques to deliver total skin electron beam therapy to frail patient while recumbent, 2023. e-Pub 2023.
      11. Wang H, Rhee DJ, Gao S, Balter P, Phan J, Lee A, Thrower S, Laneave S, Ellison D, Schipull E, Hurtt R, Netherton T, Lim TY, Mirkovic D, Luo D, Wang C, Tailor R, Wong PF, Wang X. Comparison of flattening filter free (FFF) and flattening filter (FF) photon beam VMAT plans for head and neck stereotactic body radiotherapy, 2023. e-Pub 2023.
      12. Salzillo T, Hughes N, Vedam S, Lim TY, Wang X, Wang H, Mohammedsaid M, Fuller CD, Wang J, Yang J. Clinical Development of CT Simulations for MR-Linac Patients without the Use of a CT Table Overlay, 2023. e-Pub 2023.
      13. Jacinto JC, Lim TY, Wang X, Briere TM, McGovern SL, Paulino A. Feasibility of Deep Inspiration Breath Hold Technique and Local Control in Pediatric Hodgkin Lymphoma, 2022. e-Pub 2022.
      14. Prajapati S, Yu Z, Zhao Y, Lim TY, Wang H, Wang X, Lee B, Castillo P, Sobremonte A, Farooqi A, Mitra D, Kudchadker R, Tang C, Yang J. Quantifying Setup Uncertainties in Treating Intramuscular Metastases with Image-Guided Radiation Therapy, 2022. e-Pub 2022.
      15. Wang H, Han E, Phan J, Lim TY, Yang J, Pham M, Wang X. Feasibility of Stereotactic Radiotherapy for Base of Tongue Cancers On the MR-Linac, 2022. e-Pub 2022.
      16. Wang H, Chen X, Zhao Y, Wang X, Han E, Lim TY, Yu Z, Prajapati S, Yang J. Evaluation of Delivered Dose Using Synthetic CT for MR-Guided and CT-Guided Radiotherapy, 2022. e-Pub 2022.
      17. Gronberg M, Gay S, Beadle B, Garden A, Skinner H, Netherton T, Cao W, Vazquez I, Olanrewaju A, Chung C, Cardenas C, Fuller C, Peterson C, Jhingran A, Howell R, Lim TY, Yang M, Mumme R, Court L. Deep Learning-Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiotherapy Plans, 2022. e-Pub 2022.
      18. Manzar GS, Wu S, Khan M, Corrigan KL, Yoder AK, Gunther JR, Thomas S, Manasanch EE, Lee H, Lim TY, Amini B, Lin P, Orlowski R, Patel K, Becnel MR, Kaufman G, Weber D, Dabaja B, Pinnix CC, Fang P. Outcome of Patients with Central Nervous System Multiple Myeloma (CNS-MM) Treated with CNS-Directed Radiation Therapy, 2022. e-Pub 2022.
      19. H Wang, J Yang, J Phan, E Han, Lim TY, P Castillo, X Wang. Feasibility of Skull Base Stereotactic Radiotherapy on Elekta MR-Linac, 2021. e-Pub 2021.
      20. Lim TY, Wang X, Yang J. Scoring Contour Agreement Using a Beta Distribution Model, 2020. e-Pub 2020.
      21. Cardenas C, Beadle B, Lim TY, Yang J, Olanrewaju A, Douglas R, Netherton T, Zhang L, Court L. Head and Neck CTV Decision Making and Automatic Contouring Results in More Consistent Radiotherapy Plans, 2020. e-Pub 2020.
      22. Lloyd S, Lim TY, Fave X, Flores-Martinez E, Atwood T, Moore K, Moiseenko V. Halcyon: Commissioning and the first 100 patients, 2018. e-Pub 2018.
      23. Kim G, Rah J, Lim TY, Flores-Martinez E, Pawlicki T. Feasibility Study of the Image-based Automatic QA for the Halcyon, 2018. e-Pub 2018.
      24. Lloyd S, Lim TY, Fave X, Flores-Martinez E, Moiseenko V, Moore K, Atwood T. A Simplified Commissioning Procedure for the Halcyon Linear Accelerator, 2018. e-Pub 2018.
      25. Lim TY, Flores-Martinez E, Fave X, Lloyd S, Dragojevic I, Hoffman D, Atwood T, Moore K, Kim G. Initial Investigation of the SX1 Dual-Layer Multileaf Collimator Tongue-and-Groove Effect, 2018. e-Pub 2018.
      26. Lim TY, Dragojevic I, Hoffman DB, Flores-Martinez E, Kim G. Characterization of the Halcyon SX1 Multi-Leaf Collimator System, 2018. e-Pub 2018.
      27. Lim TY, Gillespie EF, Li N, Ziemer B, Sherer M, Murphy JD, Moore KL. Dosimetric Impact of Contour Variation in Head-and-Neck Anatomy, 2017. e-Pub 2017.
      28. Lim TY, Gillespie EF, Murphy J, Moore KL. Beyond Mere Geometry: Clinically-oriented Contour Evaluation using Knowledge-based Planning, 2017. e-Pub 2017.
      29. Lim TY, Gillespie EF, Murphy JD, Moore KL. Dosimetric Indices from Automated Planning versus Geometric Conformity Indices for the Evaluation of Contour Accuracy in Head-and-Neck Cancer, 2017. e-Pub 2017.
      30. Martin GV, Pugh TJ, Mahmood U, Swanson DA, Lim TY, Kudchadker R, Graber W, Wang J, Bruno T, Bathala TK, Blanchard P, Frank SJ. Are We Ready to Replace Post-Implant CT Dosimetry? Permanent Prostate Brachytherapy Post-Implant MRI Dosimetry Using Positive Contrast MRI Markers, 2016. e-Pub 2016.
      31. Blanchard P, Pugh TJ, Mahmood U, Swanson DA, Graber WJ, Wang J, Bathala TK, Lim TY, Bruno T, Martin GV, Kudchadker RJ, Frank SJ. MRI Simulation for LDR Prostate Brachyhtherapy: Can We Replace Ultrasound with MRI for Treatment Planning? Comparison of Pre-Planning, Day 0 and Day 30 MR Dosimetry, 2016. e-Pub 2016.
      32. Lim TY, Kudchadker R, Wang J, Stafford RJ, Bruno T, Bathala T, Mahmood U, Pugh TJ, Ibbott G, Frank SJ. Initial Patient Experience With Positive-Contrast MRI Markers for Low-Dose-Rate Prostate Brachytherapy, 2015. e-Pub 2015.
      33. Lim TY, Kudchadker R, Wang J, Stafford RJ, Bruno T, Bathala T, Mahmood U, Pugh TJ, Ibbott G, Frank SJ. Sirius Markers for MRI-based Post-Implant Dosimetry: Initial Patient Experience, 2015. e-Pub 2015.
      34. Wang J, Lim TY, Kudchadker R, Pugh T, Ibbott G, Frank S. Evaluation of MR Image Distortion in Positive Contrast Markers for Low-Dose Prostate Brachytherapy, 2015. e-Pub 2015.
      35. Lim TY, Wang J, Frank SJ, Stafford RJ, Bruno T, Bathala T, Mahmood U, Pugh TJ, Ibbott G, Kudchadker RJ. MR Protocol Development to Visualize Sirius MRI Markers in Prostate Brachytherapy Patients for MR Based Post-Implant Dosimetry, 2015. e-Pub 2015.
      36. Lim TY, Wang J, Kudchadker RJ, Stafford RJ, Bathala T, Pugh TJ, Ibbott G, Frank SJ. Sirius MRI Markers for Prostate Post-Implant Assessment: MR Protocol Development, 2014. e-Pub 2014.
      37. Kudchadker RJ, Lim TY, Du W, Bruno TL, Mahmood U, Pugh TJ, Frank SJ. 131Cs Stranded-Seed Nomogram for a Prospective Phase II Intermediate-Risk Low-Dose-Rate Prostate Brachytherapy Clinical Trial, 2013. e-Pub 2013.
      38. Lim TY, Frank SJ, Pugh TJ, Bruno TL, Kudchadker RJ. Comparison of Two Commercial Treatment Planning Systems VariSeed and MIM for Low Dose Rate Prostate Brachytherapy, 2013. e-Pub 2013.
      39. Lim TY, Stafford RJ, Sankarayanapillai M, Kudchadker RJ, Frank SJ. Relaxivity Measurements of Cobalt Dichloride N-Acetyl Cysteine for MRI-based Prostate Brachytherapy, 2013. e-Pub 2013.
      40. Lim TY, Stafford RJ, Sankaranarayanapillai M, Martirosyan M, Kudchadker RJ, Frank SJ. MRI Characteristics of Cobalt Dichloride N-Acetyl Cysteine (C4) as a Contrast Agent Marker for Prostate Brachytherapy, 2013. e-Pub 2013.
      41. Lim TY, Ma JF. Image-based determination of the fat signal model for Dixon water and fat imaging, 2012. e-Pub 2012.
      42. Lim TY, Rosen GL. Random Indexing to Reduce Feature Dimensions Used in Taxonomic Classification of Next-generation Reads, 2010. e-Pub 2010.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 29, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top